MSB 2.78% $2.45 mesoblast limited

Interesting thought! One of the companies I hold has licenced a...

  1. 21 Posts.
    lightbulb Created with Sketch. 1
    Interesting thought! One of the companies I hold has licenced a technology from Upenn that allows car-t toxicity to be controlled. They plan to develop and licence out to the big players so they can make their car-t treatments safer, but maybe Novartis can make their current treatment safer with Remestemcel-L and avoid developing a new product
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$2.45
Change
-0.070(2.78%)
Mkt cap ! $1.439B
Open High Low Value Volume
$2.50 $2.51 $2.44 $7.265M 2.948M

Buyers (Bids)

No. Vol. Price($)
41 208165 $2.45
 

Sellers (Offers)

Price($) Vol. No.
$2.46 29440 2
View Market Depth
Last trade - 16.10pm 15/01/2021 (20 minute delay) ?
(live)
Last
$2.46
  Change
-0.070 ( 1.46 %)
Open High Low Volume
$2.50 $2.50 $2.44 902562
Last updated 15.59pm 15/01/2021 (live) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.